Viridian Therapeutics, Inc.

VRDNNASDAQHealthcare● Active

$15.73

$-0.05(-0.32%)

Market Cap$1.4B

P/E Ratio—

52W High$34.29

52W Low$13.18

Avg Volume2.8M

Open$16.05

Beta0.90

Insider Trades Ownership Employees

Viridian Therapeutics, Inc.（VRDN）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · VRDN · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

2.00

Buy/Sell (by trades)

整体情绪

偏多

↑ Buy 67%仅显示有效交易 · 排除RSU归属33% Sell ↓

Viridian Therapeutics, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

VRDN 季度内部人买卖趋势

VRDN 内幕交易卖出 · VRDN 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

1.6M813K0

2024 Q2

2024 Q3

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

活跃内部人

近12个月交易最活跃 · VRDN CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

VRDN 高管卖出股份 · VRDN 董事内幕交易 · SEC Form 4申报

显示最近 27 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
May 11, 2026	Fairmount Funds Management LLC Director	Purchase	1,176,470	$17.00	$20.00M⚡	5,090,928	Form 4
Mar 3, 2026	Tousignant Jennifer Chief Legal Officer	Option	5,169	—	—	5,169	Form 4
Mar 3, 2026	Tousignant Jennifer Chief Legal Officer	Other	1,724	$29.32	$51K	3,445	Form 4
Mar 3, 2026	Harmon Seth CFO	Option	6,267	—	—	9,881	Form 4
Mar 3, 2026	Harmon Seth CFO	Other	2,091	$29.32	$61K	7,790	Form 4
Mar 3, 2026	Beetham Thomas W. COO	Option	9,409	—	—	16,409	Form 4
Mar 3, 2026	Beetham Thomas W. COO	Other	3,138	$29.32	$92K	13,271	Form 4
Mar 3, 2026	Mahoney Stephen F. President and CEO	Option	18,357	—	—	40,757	Form 4
Mar 3, 2026	Mahoney Stephen F. President and CEO	Other	7,627	$29.32	$224K	33,130	Form 4
Dec 31, 2025	Tousignant Jennifer Chief Legal Officer	Sale	2,272	$31.16	$71K	0	Form 4
Oct 23, 2025	Fairmount Funds Management LLC Director	Purchase	454,545	$22.00	$10.00M⚡	3,914,458	Form 4
Jun 10, 2025	Fairmount Funds Management LLC Director	Option	12,500	$12.31	$154K	3,459,913	Form 4
Jun 9, 2025	Fairmount Funds Management LLC Director	Option	1,600	$7.80	$12K	3,447,413	Form 4
Sep 27, 2024	Beetham Thomas W. COO	Purchase	5,000	$23.41	$117K	6,000	Form 4
Sep 27, 2024	Mahoney Stephen F. President and CEO · Director	Purchase	21,400	$23.33	$499K	21,400	Form 4
Sep 13, 2024	Fairmount Funds Management LLC Director	Purchase	1,600,000	$18.75	$30.00M⚡	3,445,813	Form 4
Mar 28, 2024	Fairmount Funds Management LLC Director	Other	5,859	—	—	1,845,813	Form 4
Mar 28, 2024	Fairmount Funds Management LLC Director	Other	5,859	—	—	0	Form 4
Jan 22, 2024	Fairmount Funds Management LLC Director	Purchase	476,190	$21.00	$10.00M⚡	1,839,954	Form 4
Jun 15, 2023	Meisner Lara Chief Legal Officer	Option	2,269	$23.03	$52K	32,240	Form 4
Jun 16, 2023	Meisner Lara Chief Legal Officer	Option	27	$23.03	$622	29,998	Form 4
Jun 15, 2023	Meisner Lara Chief Legal Officer	Sale	2,269	$28.02	$64K	29,971	Form 4
Jun 16, 2023	Meisner Lara Chief Legal Officer	Sale	27	$28.35	$765	29,971	Form 4
Jun 6, 2023	Meisner Lara Chief Legal Officer	Option	5,126	$18.51	$95K	35,097	Form 4
Jun 2, 2023	Meisner Lara Chief Legal Officer	Option	1,875	$14.00	$26K	31,846	Form 4

Fairmount Funds Management LLC

Director

Purchase

日期

May 11

股数

1,176,470

均价

$17.00

总金额

$20.00M ⚡

View Form 4 on SEC.gov

Tousignant Jennifer

Chief Legal Officer

Option

日期

Mar 3

股数

5,169

均价

—

总金额

—

View Form 4 on SEC.gov

Tousignant Jennifer

Chief Legal Officer

Other

日期

Mar 3

股数

1,724

均价

$29.32

总金额

$51K

View Form 4 on SEC.gov

Harmon Seth

CFO

Option

日期

Mar 3

股数

6,267

均价

—

总金额

—

View Form 4 on SEC.gov

Harmon Seth

CFO

Other

日期

Mar 3

股数

2,091

均价

$29.32

总金额

$61K

View Form 4 on SEC.gov

Beetham Thomas W.

COO

Option

日期

Mar 3

股数

9,409

均价

—

总金额

—

View Form 4 on SEC.gov

Beetham Thomas W.

COO

Other

日期

Mar 3

股数

3,138

均价

$29.32

总金额

$92K

View Form 4 on SEC.gov

Mahoney Stephen F.

President and CEO

Option

日期

Mar 3

股数

18,357

均价

—

总金额

—

View Form 4 on SEC.gov

Mahoney Stephen F.

President and CEO

Other

日期

Mar 3

股数

7,627

均价

$29.32

总金额

$224K

View Form 4 on SEC.gov

Tousignant Jennifer

Chief Legal Officer

Sale

日期

Dec 31

股数

2,272

均价

$31.16

总金额

$71K

View Form 4 on SEC.gov

Fairmount Funds Management LLC

Director

Purchase

日期

Oct 23

股数

454,545

均价

$22.00

总金额

$10.00M ⚡

View Form 4 on SEC.gov

Fairmount Funds Management LLC

Director

Option

日期

Jun 10

股数

12,500

均价

$12.31

总金额

$154K

View Form 4 on SEC.gov

Fairmount Funds Management LLC

Director

Option

日期

Jun 9

股数

1,600

均价

$7.80

总金额

$12K

View Form 4 on SEC.gov

Beetham Thomas W.

COO

Purchase

日期

Sep 27

股数

5,000

均价

$23.41

总金额

$117K

View Form 4 on SEC.gov

Mahoney Stephen F.

President and CEO · Director

Purchase

日期

Sep 27

股数

21,400

均价

$23.33

总金额

$499K

View Form 4 on SEC.gov

Fairmount Funds Management LLC

Director

Purchase

日期

Sep 13

股数

1,600,000

均价

$18.75

总金额

$30.00M ⚡

View Form 4 on SEC.gov

Fairmount Funds Management LLC

Director

Other

日期

Mar 28

股数

5,859

均价

—

总金额

—

View Form 4 on SEC.gov

Fairmount Funds Management LLC

Director

Other

日期

Mar 28

股数

5,859

均价

—

总金额

—

View Form 4 on SEC.gov

Fairmount Funds Management LLC

Director

Purchase

日期

Jan 22

股数

476,190

均价

$21.00

总金额

$10.00M ⚡

View Form 4 on SEC.gov

Meisner Lara

Chief Legal Officer

Option

日期

Jun 15

股数

2,269

均价

$23.03

总金额

$52K

View Form 4 on SEC.gov

Meisner Lara

Chief Legal Officer

Option

日期

Jun 16

股数

均价

$23.03

总金额

$622

View Form 4 on SEC.gov

Meisner Lara

Chief Legal Officer

Sale

日期

Jun 15

股数

2,269

均价

$28.02

总金额

$64K

View Form 4 on SEC.gov

Meisner Lara

Chief Legal Officer

Sale

日期

Jun 16

股数

均价

$28.35

总金额

$765

View Form 4 on SEC.gov

Meisner Lara

Chief Legal Officer

Option

日期

Jun 6

股数

5,126

均价

$18.51

总金额

$95K

View Form 4 on SEC.gov

Meisner Lara

Chief Legal Officer

Option

日期

Jun 2

股数

1,875

均价

$14.00

总金额

$26K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 VRDN 内幕交易

VRDN 内幕交易

Viridian Therapeutics, Inc.（VRDN）内幕交易数据来源于公司内部人（包括Fairmount Funds Management LLC (Director), Tousignant Jennifer (Chief Legal Officer), Harmon Seth (CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。VRDN内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Viridian Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

VRDN 内幕交易 · 5个问题

Viridian Therapeutics, Inc.（VRDN）的内部人包括高管和董事，如Fairmount Funds Management LLC (Director), Tousignant Jennifer (Chief Legal Officer), Harmon Seth (CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

VRDN 董事内幕交易VRDN 内部人名单Viridian Therapeutics, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026